Spots Global Cancer Trial Database for docetaxel and gemcitabine
Every month we try and update this database with for docetaxel and gemcitabine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma | NCT00183794 | Ovarian Carcino... Peritoneal Neop... | Docetaxel and G... | 18 Years - | University of Southern California | |
Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. | NCT00425191 | Non-small Cell ... | Docetaxel and G... Docetaxel and G... Gemcitabine cis... | 18 Years - 70 Years | Sanofi |